Ledger.Open graph →
SEC Form D · Amendment · filed October 13, 2010

Eleven Biotherapeutics, Inc

Offering
$35.0M
Sold
$8.8M
Exemption
—
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

People & firms on this filing (9)

Mark Levin · Cambridge, MAExec · DirectorRudolphe S. Otter · PASADENA, CADirectorDavid E. Flynn · Draper, UTExec · DirectorKim C. Drapkin · Cambridge, MAExecGavin L. James · PASADENA, CADirectorSteven E. Brox · Draper, UTExec · DirectorLarry Zulch · Walnut Creek, CAExec · DirectorNoubar B. Afeyan · Cambridge, MADirectorKim C. Drapkin · Cambridge, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗